Literature DB >> 27712569

Liposomal Drug Delivery System for Cancer Therapy: Advancement and Patents.

Sheetal Jha1, Pramod K Sharma, Rishabha Malviya.   

Abstract

BACKGROUND: In this review article, authors reviewed about the liposomes which are amongst various drug delivering systems for the delivery of the therapeutic agents at the target site.
METHODS: Advances in liposomal drug delivery systems for the cancer therapy have enhanced the therapeutic levels of the anticancer moieties. Liposomes show promising action on the tumor by incorporating less amount of drug at the target site, with minimum toxic effect and maximum therapeutic effect and thereby enhancing the bioavailability.
RESULTS: Liposome-based drug delivery systems provide the potential to elevate the effect of drug concentration in tumor cells. Manuscript briefly describes the role of liposomes in cancer therapy and various patents based on the same. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Liposomes; cancer therapy; nanocarrier; patent; targeted drug delivery

Mesh:

Substances:

Year:  2016        PMID: 27712569     DOI: 10.2174/1872211310666161004155757

Source DB:  PubMed          Journal:  Recent Pat Drug Deliv Formul        ISSN: 1872-2113


  5 in total

Review 1.  Liposomes: structure, composition, types, and clinical applications.

Authors:  Hamdi Nsairat; Dima Khater; Usama Sayed; Fadwa Odeh; Abeer Al Bawab; Walhan Alshaer
Journal:  Heliyon       Date:  2022-05-13

2.  Therapeutic Efficacy Evaluation of Pegylated Liposome Encapsulated With Vinorelbine Plus 111In Repeated Treatments in Human Colorectal Carcinoma With Multimodalities of Molecular Imaging.

Authors:  Yi-Chun Chien; Ying-Hsiang Chou; Wei-Hsun Wang; John Chun-Hao Chen; Wen-Shin Chang; Chia-Wen Tsai; DA-Tian Bau; Jeng-Jong Hwang
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

3.  [18F]-Fluorinated Carboplatin and [111In]-Liposome for Image-Guided Drug Delivery.

Authors:  Narottam Lamichhane; Gajanan K Dewkar; Gobalakrishnan Sundaresan; Rebecca N Mahon; Jamal Zweit
Journal:  Int J Mol Sci       Date:  2017-05-18       Impact factor: 5.923

Review 4.  Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend.

Authors:  Hanne Locy; Sven de Mey; Wout de Mey; Mark De Ridder; Kris Thielemans; Sarah K Maenhout
Journal:  Front Immunol       Date:  2018-12-11       Impact factor: 7.561

Review 5.  Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine.

Authors:  Bahare Salehi; Zeliha Selamoglu; Ksenija S Mileski; Raffaele Pezzani; Marco Redaelli; William C Cho; Farzad Kobarfard; Sadegh Rajabi; Miquel Martorell; Pradeep Kumar; Natália Martins; Tuhin Subhra Santra; Javad Sharifi-Rad
Journal:  Biomolecules       Date:  2019-11-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.